Dr. David Steensma, expert on
acute myeloid leukemia (
AML) explains that some cases of AML do not go into
remission, or become less active, or AML may return after treatment. The U.S. Food and Drug Administration has recently approved several new drugs to treat AML when this happens. However, people with AML that comes back after a
stem cell transplant face more challenges.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about AML which will help other patients, caregivers and families.